247 related articles for article (PubMed ID: 19715608)
1. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.
Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z
J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C.
Blanc JF; Lalanne C; Plomion C; Schmitter JM; Bathany K; Gion JM; Bioulac-Sage P; Balabaud C; Bonneu M; Rosenbaum J
Proteomics; 2005 Sep; 5(14):3778-89. PubMed ID: 16097030
[TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma.
Zhang D; Lim SG; Koay ES
Int J Oncol; 2007 Sep; 31(3):577-84. PubMed ID: 17671684
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu T; Xue R; Huang X; Zhang D; Dong L; Wu H; Shen X
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):542-50. PubMed ID: 21659380
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
6. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus.
Yokoyama Y; Kuramitsu Y; Takashima M; Iizuka N; Toda T; Terai S; Sakaida I; Oka M; Nakamura K; Okita K
Proteomics; 2004 Jul; 4(7):2111-6. PubMed ID: 15221772
[TBL] [Abstract][Full Text] [Related]
8. Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma.
Kim W; Oe Lim S; Kim JS; Ryu YH; Byeon JY; Kim HJ; Kim YI; Heo JS; Park YM; Jung G
Clin Cancer Res; 2003 Nov; 9(15):5493-500. PubMed ID: 14654528
[TBL] [Abstract][Full Text] [Related]
9. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics.
Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y
Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
11. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
12. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
13. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
14. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers.
Li C; Tan YX; Zhou H; Ding SJ; Li SJ; Ma DJ; Man XB; Hong Y; Zhang L; Li L; Xia QC; Wu JR; Wang HY; Zeng R
Proteomics; 2005 Mar; 5(4):1125-39. PubMed ID: 15759316
[TBL] [Abstract][Full Text] [Related]
17. Analysis of microRNA expression profiles in human hepatitis B virus-related hepatocellular carcinoma.
Li J; Shi W; Gao Y; Yang B; Jing X; Shan S; Wang Y; Du Z
Clin Lab; 2013; 59(9-10):1009-15. PubMed ID: 24273923
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma.
Takashima M; Kuramitsu Y; Yokoyama Y; Iizuka N; Toda T; Sakaida I; Okita K; Oka M; Nakamura K
Proteomics; 2003 Dec; 3(12):2487-93. PubMed ID: 14673798
[TBL] [Abstract][Full Text] [Related]
19. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
[TBL] [Abstract][Full Text] [Related]
20. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
